Volume 11, Issue 2 ( June 2019 2019)                   Iranian Journal of Blood and Cancer 2019, 11(2): 72-74 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Karami H, Naderisorki M, Ghasemi M, Sakhaei S M. Immune Thrombocytopenia as a Primary Sign of Relapse in Hodgkin Lymphoma: A Case Report. Iranian Journal of Blood and Cancer 2019; 11 (2) :72-74
URL: http://ijbc.ir/article-1-917-en.html
Immune Thrombocytopenia as a Primary Sign of Relapse in Hodgkin Lymphoma: A Case Report
Hossein Karami1 , Mohammad Naderisorki *2 , Maryam Ghasemi3 , Sayed Mohammad Sakhaei4
1- Thalassemia Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
2- Thalassemia Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran , dr.naderisorki@gmail.com
3- Associate Professor of Pathology, Immunogenetics Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
4- Assistant Professor of Interventional Radiology, Department of Radiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Abstract:   (3893 Views)
Hodgkin lymphoma (HL) as a malignant tumor presents with lymphadenopathy and systemic complaints. The origin of this tumor is mostly suggested to be B lymphocytes. There is a close relationship between autoimmunity and HL, but the mechanism of this immune syndromes is unclear. Immune thrombocytopenia (ITP) is the most common autoimmune syndrome which may present before, at the same time, and even after treatment of the HL. We present a case of ITP as a primary sign of relapse of HL in a 15-year-old boy after complete treatment of HL.
Keywords: Hodgkin lymphoma, Immune thrombocytopenia, Relapse, Autoimmunity
Full-Text [PDF 384 kb]   (2368 Downloads)    
: Case report | Subject: Pediatric Hematology & Oncology
Received: 2019/07/27 | Accepted: 2019/07/29 | Published: 2019/08/17
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb